Evidence map›Paper›PMID 33857734›Full record

ArticleJournal of the neurological sciences2021

Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease.

Udo Zifko, Theresa Schmiedlechner, Johan Saelens, Katharina Zifko, Michael Wagner, Ojan Assadian, Wolfgang Grisold, Harald Stingl

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the neurological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis.medRxiv : the preprint server for health sciences · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Udo ZifkoNeurologische Abteilung, Evangelisches Krankenhaus, Hans-Sachs-Gasse 10-12, 1180 Wien, Austria. Electronic address: ordination@zifko.at.
Theresa SchmiedlechnerNeurologische Abteilung, Evangelisches Krankenhaus, Hans-Sachs-Gasse 10-12, 1180 Wien, Austria.
Johan SaelensMedizinische Universität Wien, Spitalgasse 23, 1090 Wien, Austria.
Katharina ZifkoMedizinische Universität Wien, Spitalgasse 23, 1090 Wien, Austria.
Michael WagnerInterne Abteilung, Landesklinikum Melk, Krankenhausstraße 11, 3390 Melk, Austria.
Ojan AssadianÄrztliche Direktion, Landesklinikum Wiener Neustadt, Corvinusring 3-5, 2700 Wiener Neustadt, Austria.
Wolfgang GrisoldLudwig-Boltzmann-Institute for Experimental and Clinical Traumatology, Donaueschingenstraße 13, A-1200 Wien, Austria.
Harald StinglInterne Abteilung, Landesklinikum Melk, Krankenhausstraße 11, 3390 Melk, Austria.
Medical University of Vienna · ATFachhochschule Wiener Neustadt · ATLudwig Boltzmann Institute for Experimental and Clinical Traumatology · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main objective of this study was to analyse neurological symptoms during a Covid-19 infection and determine the pattern of symptoms by comparing outpatients with inpatients. A further goal was to identify possible predictors, such as pre-existing conditions and neurological symptoms. We recorded the clinical data of 40 inpatients and 42 outpatients in this retrospective, cross sectional study. Of them, 68 patients (83%), evenly distributed between the two groups, suffered from neurological symptoms. We identified the onset of neurological symptoms and the related time ranges in 41 patients (36 outpatients and 5 inpatients). Of these, 63.4% reported neurological symptoms on the first or second day of illness. 49 patients (72%) showed combinations of at least two to a maximum of seven different neurological symptoms. A more severe course of disease was correlated with age and male sex, but age was not identified as a predictor for the occurrence of neurological symptoms. Women suffered from central and neuromuscular symptoms more often than men (p = 0,004). The most common symptoms were fatigue (54%), headache (31%), loss of taste (31%), and loss of smell (27%). Pre-existing dementia was associated with increased lethality; similarly, pre-existing stroke was associated with a more severe course of Covid-19 infection. Hallucinations and confusion were related to an increased likelihood of death. The present data demonstrate the importance of comprehensive neurological support of inpatients and outpatients affected by Covid-19.

Indexed as

COVID-19Cross-Sectional StudiesFemaleHumansMaleNervous SystemRetrospective StudiesSARS-CoV-2Covid-19InpatientNeurological symptomOutpatientPredictor of severityPre-existing neurological conditionSARS-CoV-2

Identifiers

PMID33857734
PMCPMC8028603
OpenAlexW3141324290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.